Refractory Diffuse Intrinsic Pontine Glioma

specific

Diffuse intrinsic pontine glioma that is resistant to treatment.

Centers

Active Trials

—

Cancer Funding

Top Centers for Refractory Diffuse Intrinsic Pontine Glioma(7)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Research Tier	Active Trials	Cancer Funding	Score
1	Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program	Active Research Program	2	—	66.8
2	University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program	Active Research Program	2	—	66.8
3	University of Illinois Cancer CenterChicago, IL Active Research Program	Active Research Program	2	—	66.8
4	University of Cincinnati Cancer CenterCincinnati, OH Active Research Program	Active Research Program	2	—	66.8
5	Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive		—	—	44.3
6	Comprehensive Cancer Center St. Jude Children’s Research HospitalMemphis, TN NCI Comprehensive		—	—	44.3
7	University of Texas Medical Branch Cancer CenterGalveston, TX		—	—	44.3

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →